IP Library Patent Application 18179196
Patent Application
App. No. 18/179,196

BUPROPION AS A MODULATOR OF DRUG ACTIVITY

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/179,196
Abstract

Dosage forms, drug delivery systems, and methods related to sustained release of dextromethorphan or improved therapeutic effects are disclosed. Typically, bupropion or a related compound is orally administered to a human being to be treated with, or being treated with, dextromethorphan.

Claims (7)

1 . A method of treating generalized anxiety disorder, comprising administering a combination of dextromethorphan and bupropion to a human being in need thereof.

2 . The method of claim 1 , wherein about 45 mg of the dextromethorphan is orally administered once a day or twice a day.

3 . The method of claim 1 , wherein about 100 mg to about 120 mg of the bupropion is orally administered once a day or twice a day.

4 . The method of claim 1 , wherein about 105 mg of the bupropion is orally administered once a day or twice a day.

5 . The method of claim 1 , wherein the dextromethorphan is orally administered in a dosage form that provides immediate release of the dextromethorphan.

6 . The method of claim 1 , wherein the bupropion is orally administered in a dosage form that provides sustained release of the bupropion.

7 . The method of claim 1 , wherein the bupropion and the dextromethorphan are orally administered together in a single dosage form that is orally administered once a day or twice a day.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2023
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 063524/0142 →